U.S. Software Stock News

NYSE:GMED
NYSE:GMEDMedical Equipment

Is It Time To Reassess Globus Medical (GMED) After Recent Share Price Swings?

Investors may be wondering whether Globus Medical at around US$84.81 is offering good value right now, or whether the recent excitement has already been priced in. The stock has had a mixed run recently, up 10.7% over the past week, while down 10.7% over the past month and down 2.9% year to date. It has also delivered a 43.8% return over the past year and 60.2% over three years. These moves have kept Globus Medical on many investors' radars as broader interest in medical technology and...
NYSE:APG
NYSE:APGConstruction

Will APi Group’s (APG) Expanded US$1 Billion Revolver and New Notes Reshape Its Investment Narrative

APi Group Corporation recently closed two major financing transactions, issuing US$500 million of 5.75% senior notes due 2034 and amending its credit agreement to extend term loan and revolving credit maturities while increasing the revolver to US$1.00 billion. By locking in longer-dated debt and expanding its revolving credit capacity, APi Group has materially increased its financial flexibility to fund acquisitions and other corporate initiatives. We will now examine how APi Group’s...
NYSE:EME
NYSE:EMEConstruction

Is It Too Late To Consider EMCOR Group (EME) After An 83.6% One-Year Surge?

Wondering if EMCOR Group is still reasonably priced after such a strong run, or if you are arriving late? This article walks through the key signals that matter for value focused investors. The stock trades at US$848.91, after a 7 day decline of 7%, a 1 month decline of 1.3%, and a year to date gain of 32.9%, with the last 12 months showing an 83.6% return and a very large 3 year gain of roughly 5x. These moves come as EMCOR Group continues to attract attention in the capital goods sector...
NYSE:FBIN
NYSE:FBINBuilding

Does Fortune Brands Innovations (FBIN) Mixed Quarter Reveal an Execution Gap in Its Transformation Strategy?

In the past quarter, Fortune Brands Innovations reported slightly lower year-on-year revenue but higher-than-expected adjusted operating income, while trailing peers in the home construction materials sector. This combination of mixed results and relative underperformance has sharpened investor focus on how effectively the company is executing its transformation plans versus competitors. Next, we’ll examine how this mixed quarter, particularly the weaker performance versus peers, may...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Is Up 9.9% After Merck Tie-Up And IP Challenge To ERAS-0015 - Has The Bull Case Changed?

Erasca, Inc. recently reported a first-quarter 2026 net loss of US$183.44 million and entered a past clinical trial collaboration and supply agreement with Merck to test its pan-RAS molecular glue ERAS-0015 alongside KEYTRUDA in RAS-mutant solid tumors. Soon after, Revolution Medicines’ patent infringement and trade secret claims against ERAS-0015 and the launch of multiple law firm investigations raised fresh questions about the durability of Erasca’s intellectual property position and...
NYSE:ENS
NYSE:ENSElectrical

Will Record 2026 Sales, Softer EPS and Upbeat Outlook Shift EnerSys' (ENS) Realignment Narrative?

EnerSys recently reported full-year 2026 results showing record net sales of US$3.75 billion, modest revenue growth over the prior year, but lower net income of US$293.56 million and reduced earnings per share. Alongside these results, the company raised attention with stronger-than-expected guidance for early fiscal 2027, continued dividends, and new battery products targeting data centers and outdoor communications networks. We’ll now examine how record sales, upbeat guidance, and cost...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Hyliion Holdings (HYLN) Is Up 28.3% After Navy Selects KARNO For USX-1 Power Trials – Has The Bull Case Changed?

In May 2026, Hyliion Holdings Corp. announced that the U.S. Navy’s Office of Naval Research, working with DARPA, had selected the unmanned USX-1 Defiant vessel to test an 800 KW shipboard power system built from four 200 KW KARNO Cores under a funded sea trials program. This Navy deployment, arriving shortly after Hyliion’s lab proof of seamless multi-fuel operation for its next-generation KARNO reactor, highlights how fuel-flexible, low-maintenance onboard power is being evaluated for...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Is Trump Media & Technology Group (DJT) Fairly Priced After Sharp One-Year Share Price Decline

If you are looking at Trump Media & Technology Group and wondering whether the current share price reflects the underlying value, the recent moves give you plenty to think about. The stock closed at US$7.95, with the share price down 8.3% over the past week, down 16.1% over the past month and down 42.3% year to date, contributing to a 69.1% decline over the last year and a 39.0% decline over three years. Recent headlines around Trump Media & Technology Group have kept the stock in the...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

Assessing TeraWulf (WULF) Valuation After HPC Lease Growth And New Power Campus Expansion

TeraWulf (WULF) stock has been moving after fresh updates on its high performance computing lease revenue, liquidity, and expansion projects, including progress at Lake Mariner and a new power rich campus acquisition in Kentucky. See our latest analysis for TeraWulf. The latest construction milestones and executive equity vesting arrive after a powerful run, with the stock’s 90 day share price return of 52.03% and a very large 1 year total shareholder return. This hints that investors are...
NYSE:TEN
NYSE:TENOil and Gas

Tsakos Energy Navigation (TNP) EPS Surge Reinforces Bullish Profitability Narratives

Tsakos Energy Navigation (NYSE:TNP) opened 2026 with Q1 revenue of US$252.9 million and basic EPS of US$2.72, against a backdrop of trailing 12 month revenue of US$854.6 million and EPS of US$6.14 that was paired with 39.1% year over year earnings growth. Over recent quarters the company has seen revenue move from US$188.3 million in Q4 2024 to US$197.1 million in Q1 2025 and then to US$222.1 million in Q4 2025 before reaching the latest US$252.9 million print. Quarterly EPS shifted from...
NYSE:TSN
NYSE:TSNFood

What Tyson Foods (TSN)'s US$48 Million Pork Antitrust Settlement Means For Shareholders

In May 2026, Tyson Foods and related entities agreed to a US$48,000,000 settlement in a long-running federal antitrust class action over alleged pork price-fixing affecting commercial and institutional buyers across multiple U.S. jurisdictions, while denying any wrongdoing and awaiting court approval before any payouts occur. The settlement also obligates Tyson to provide non-monetary relief and cooperate with plaintiffs pursuing claims against other pork producers, potentially reshaping...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix AMD Share Deal Raises Questions On Valuation And Future Alignment

Nutanix (NasdaqGS:NTNX) has issued over 4.1 million shares to AMD under a stock purchase agreement. The transaction, recently completed, totals US$150 million in new Nutanix equity issued to AMD. This share issuance introduces a large technology peer as a direct shareholder in Nutanix. Nutanix focuses on cloud software and hyperconverged infrastructure, with the goal of simplifying how enterprises run applications and data across private and public clouds. In the context of ongoing cloud...
NYSE:OTIS
NYSE:OTISMachinery

Did Otis Link MOD’s Global Escalator Upgrade Push Just Shift Otis Worldwide’s (OTIS) Investment Narrative?

Otis Worldwide recently launched its Otis Link MOD suite of commercial escalator modernization solutions worldwide, offering modular packages that upgrade safety, reliability, and efficiency for aging escalators while minimizing disruption by retaining existing trusses and using factory-preassembled components. A key insight is that Otis is targeting a modernization window covering roughly one-fifth of the world’s more than 1 million escalators, pairing this demand with IoT-enabled...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Assessing Veeva Systems (VEEV) Valuation After A Prolonged Share Price Decline

Recent performance snapshot Veeva Systems (VEEV) has been on many investors’ radar after a challenging run, with the stock down about 27% year to date and about 31% over the past year. Over the past month the share price fell about 2%, extending a past 3 months decline of roughly 11%, even as the company reports annual revenue of US$3.20b and net income of US$908.91m. See our latest analysis for Veeva Systems. The stock’s short-term share price momentum has faded, with the 90 day share price...
NYSE:VSH
NYSE:VSHElectronic

A Look At Vishay Intertechnology (VSH) Valuation After Profit Return And EV Product Launches

Vishay Intertechnology (VSH) stock has been in focus after the company returned to profitability in Q1 2026 and issued Q2 revenue guidance, with fresh EV focused optocoupler launches adding a product driven angle. See our latest analysis for Vishay Intertechnology. The recent Q1 return to profitability, new EV-focused product launches, and sector-wide enthusiasm around AI infrastructure have coincided with sharp momentum. The 30-day share price return of 75.4% and 1-year total shareholder...
NYSE:ET
NYSE:ETOil and Gas

Dakota Access Approval Refocuses Energy Transfer Risk And Growth Outlook

U.S. Army Corps of Engineers grants final approval for the Dakota Access Pipeline to remain operational. Approval includes new environmental safeguards focused on leak detection and groundwater monitoring. Decision directly affects Energy Transfer (NYSE:ET), which operates the Dakota Access Pipeline. Energy Transfer (NYSE:ET) is a major U.S. midstream company focused on transporting and storing oil and natural gas through a large pipeline network. The Army Corps decision on the Dakota...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Stronger Senior Housing And Credit Upgrade Might Change The Case For Investing In DHC

Diversified Healthcare Trust recently reported that its first-quarter results marked a move from stabilization to growth, underpinned by stronger senior housing operations, improved liquidity, and a credit rating upgrade that collectively eased perceived risk. The company also disclosed that its CEO and CFO previously presented at Nareit’s REITweek 2026 Investor Conference, offering investors additional insight into this evolving growth story. We’ll now explore how the shift from...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Faces Taiwan Smuggling Crackdown And Expanding U.S. Legal Risks

Taiwanese authorities have launched a semiconductor smuggling crackdown, detaining individuals accused of forging export documents to ship Super Micro Computer's AI servers with Nvidia chips to China. The Taiwan probe comes on top of multiple U.S. securities class action lawsuits and a DOJ indictment that includes alleged large-scale export control violations, obstruction, and fabrication of audit data by a senior executive. These actions expand legal and compliance risks for Super Micro...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter International (BAX) Is Up 10.9% After Q1 Revenue Beat Refocuses Margin Recovery Narrative

Baxter International recently reported a strong first quarter, with revenue rising 2.9% year on year and exceeding analysts’ forecasts, following earlier indications of undervaluation and planned insider share sales disclosed via a Form 144 filing. This combination of better-than-expected operational performance and prior signals of perceived intrinsic value has sharpened attention on how effectively Baxter is executing its ongoing transformation efforts. With revenue outperforming...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Assessing ImmunityBio (IBRX) Valuation After FDA Acceptance Of Anktiva sBLA For Papillary NMIBC

ImmunityBio (IBRX) is back in focus after the U.S. Food and Drug Administration accepted a supplemental Biologics License Application for Anktiva plus BCG in BCG unresponsive papillary non muscle invasive bladder cancer. See our latest analysis for ImmunityBio. Despite the latest sBLA news and recent patents and supply deals around Anktiva and BCG, ImmunityBio’s share price has cooled, with a 7 day share price return down 9.41% and a 30 day share price return down 10.53%, although the year to...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

Jefferies Upgrade Puts C.H. Robinson AI Plans And Valuation In Focus

Jefferies has upgraded C.H. Robinson Worldwide (NasdaqGS:CHRW), citing the company's AI driven transformation and productivity push. The report points to C.H. Robinson's plan to use AI and automation to reshape its operations and improve efficiency. Jefferies also highlights the potential for C.H. Robinson to play a larger role in industry consolidation following the recent Supreme Court ruling in Montgomery vs. Caribe Transport II. C.H. Robinson enters this phase of change with its stock...
NYSE:DELL
NYSE:DELLTech

Is It Too Late To Consider Dell Technologies (DELL) After Its 131% Year To Date Surge?

With Dell Technologies trading at US$295.19, you might be wondering whether the stock still offers value or if most of the easy gains are already behind it. The share price movement has been strong, with returns of 22.0% over the past week, 37.5% over the past month and 131.0% year to date, while the 1 year return sits at 167.3% and the 3 and 5 year returns are both very large. Recent headlines have focused on Dell Technologies in areas such as AI related demand, enterprise hardware spending...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

Is PepsiCo (PEP) Offering Value After Mixed Returns And DCF Upside Signals

Investors may be considering whether PepsiCo stock is offering fair value at around US$150, or if the recent price still leaves some upside potential for patient investors. Over the past year, PepsiCo has returned 21.1%, with the stock up 1.0% over the last 7 days, down 2.1% over the last 30 days, and up 5.9% year to date. Taken together, this provides a mixed picture of recent sentiment. At the same time, investors have been watching ongoing product launches and brand activity across...
NYSE:P
NYSE:PTech

Assessing Everpure (P) Valuation After Strong Recent Share Price Performance

Everpure’s recent performance snapshot Everpure (P) has drawn attention after a strong recent performance, with the stock up 10.4% in the past day and 25.7% over the past month, alongside annual revenue of US$3.66b and net income of US$188.18m. See our latest analysis for Everpure. The recent 10.4% 1 day share price return at US$87.20 adds to a strong short term run, while the 1 year total shareholder return of 57.3% and very large 5 year total shareholder return suggest sustained momentum...